RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+60.85%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$5.96B
AUM Growth
+$5.96B
(+44%)
Cap. Flow
+$508M
Cap. Flow
% of AUM
8.52%
Top 10 Holdings %
Top 10 Hldgs %
47.57%
Holding
116
New
26
Increased
35
Reduced
12
Closed
14
Top Buys
| 1 |
Arvinas
ARVN
|
$152M |
| 2 |
Globus Medical
GMED
|
$107M |
| 3 |
Tarsus Pharmaceuticals
TARS
|
$99M |
| 4 |
Pulmonx
LUNG
|
$74.8M |
| 5 |
Illumina
ILMN
|
$69.1M |
Top Sells
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$128M |
| 2 |
Baxter International
BAX
|
$86.6M |
| 3 |
Incyte
INCY
|
$30M |
| 4 |
Q32 Bio
QTTB
|
$26.9M |
| 5 |
VXRT
Vaxart
VXRT
|
$23.4M |
Sector Composition
| 1 | Healthcare | 94% |
| 2 | Financials | 0.18% |
| 3 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rocket Pharmaceuticals
RCKT
$354M
| $936M | 15.7% | 17,060,211 +247,720 | +1% | +$13.6M |
|
2
Immunovant
IMVT
$2.56B
| $351M | 5.88% | 7,592,253 +81,841 | +1% | +$3.78M |
|
3
PTC Therapeutics
PTCT
$3.92B
| $258M | 4.32% | 4,221,836 +228,550 | +6% | +$13.9M |
|
|
MRTX
4
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $232M | 3.89% | 1,054,364 -41,641 | -4% | -$9.15M |
|
5
Stoke Therapeutics
STOK
$1.08B
| $219M | 3.68% | 3,544,248 | – | – |
|
6
Alnylam Pharmaceuticals
ALNY
$58.5B
| $219M | 3.67% | 1,681,645 | – | – |
|
7
Natera
NTRA
$23.1B
| $170M | 2.86% | 1,712,234 +1,465 | +0.1% | +$146K |
|
|
DRNA
8
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $160M | 2.68% | 7,253,857 +26,444 | +0.4% | +$583K |
|
|
9
Arvinas
ARVN
$568M
| $152M | 2.55% | +1,790,996 | New | +$152M |
|
10
Vericel Corp
VCEL
$1.83B
| $140M | 2.34% | 4,517,570 +666,719 | +17% | +$20.6M |
|
11
Axsome Therapeutics
AXSM
$6.05B
| $136M | 2.29% | 1,672,416 +1,478 | +0.1% | +$120K |
|
|
12
Illumina
ILMN
$15.8B
| $134M | 2.25% | 361,778 +186,778 | +107% | +$69.1M |
|
|
CERN
13
DELISTED
Cerner Corp
CERN
| $134M | 2.24% | 1,701,680 +309,631 | +22% | +$24.3M |
|
14
Masimo
MASI
$7.59B
| $126M | 2.11% | 469,416 +19,026 | +4% | +$5.11M |
|
|
15
Globus Medical
GMED
$8.27B
| $107M | 1.8% | +1,640,859 | New | +$107M |
|
16
Avidity Biosciences
RNA
$5.99B
| $102M | 1.71% | 3,995,000 | – | – |
|
|
17
Tarsus Pharmaceuticals
TARS
$2.47B
| $99M | 1.66% | +2,463,601 | New | +$99M |
|
|
AXNX
18
DELISTED
Axonics, Inc. Common Stock
AXNX
| $94M | 1.58% | 1,883,864 | – | – |
|
|
DMTK
19
DELISTED
DermTech, Inc. Common Stock
DMTK
| $93.7M | 1.57% | 2,887,215 | – | – |
|
20
10x Genomics
TXG
$1.74B
| $93.6M | 1.57% | 660,933 | – | – |
|
21
Athira Pharma
ATHA
$15.3M
| $88.9M | 1.49% | 2,685,779 +16,866 | +0.6% | +$558K |
|
22
Establishment Labs
ESTA
$1.2B
| $87.3M | 1.46% | 2,319,138 | – | – |
|
23
Korro Bio
KRRO
$217M
| $86.8M | 1.46% | 2,461,486 | – | – |
|
24
Adverum Biotechnologies
ADVM
$64.6M
| $78.3M | 1.31% | 7,227,364 -7,400 | -0.1% | -$80.2K |
|
25
Guardant Health
GH
$8.41B
| $75M | 1.26% | 581,970 +112,472 | +24% | +$14.5M |
|